RAFAEL CANADAS ZIZZIAS

Allopathic & Osteopathic Physicians|Internal Medicine DALLAS, TX NPI 1801897616

General Payments — all program years on this page

$13,515.08

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 297
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $310.70 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $310.7017

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $7,203.2572
2019 $1,484.5341
2020 $542.8337
2021 $933.3554
2022 $2,540.2946
2023 $500.1330
2024 $310.7017

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096933321 Novo Nordisk Inc $16.26 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097583099 Novo Nordisk Inc $24.91 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103411019 ABBVIE INC. $16.92 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115479014 Amgen Inc. $22.63 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116237283 GlaxoSmithKline, LLC. $23.57 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116714569 GlaxoSmithKline, LLC. $15.11 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116758606 Renalytix AI, Inc. $14.09 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117520153 Amgen Inc. $16.45 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118161932 Boehringer Ingelheim Pharmaceuticals, Inc. $13.98 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118161934 Boehringer Ingelheim Pharmaceuticals, Inc. $14.61 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118161936 Boehringer Ingelheim Pharmaceuticals, Inc. $22.34 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118870588 Otsuka America Pharmaceutical, Inc. $23.64 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125282030 Abbott Laboratories $21.19 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135201584 Lilly USA, LLC $16.88 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135306968 Lilly USA, LLC $17.40 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139624045 SANOFI-AVENTIS U.S. LLC $16.12 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151045482 Phathom Pharmaceuticals, Inc. $14.60 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.